Additional $860,000 grant for oral Estriol MS Study

[MSUK]

Adeona Pharmaceuticals, Inc., has announced that the ongoing clinical trial of its Trimesta™ (oral estriol) drug candidate being conducted by Dr. Rhonda Voskuhl, Director, UCLA Multiple Sclerosis Program, UCLA Dept. of Neurology has received an additional $860,440 in grant funding through the American Recovery and Reinvestment Act............... http://tinyurl.com/6xkx5w